Why is Beryl Drugs falling/rising?

As of 26-Sep, Beryl Drugs Ltd is experiencing a decline in its stock price, currently at Rs 22.39, which reflects a decrease of Rs 1.36 or 5.73%. The stock has underperformed its sector by 3.39% today and has been on a consecutive downward trend for the last two days, accumulating a total loss of 7.44% during this period. The stock reached an intraday low of Rs 21.5, marking a significant drop of 9.47%. Over the past week, Beryl Drugs has seen a return of -1.97%, and over the past month, it has declined by 12.20%. Year-to-date, the stock has fallen by 38.06%, contrasting sharply with the Sensex, which has gained 2.93% during the same timeframe. Notably, the stock's delivery volume has plummeted by 93.96% against its five-day average, indicating a significant drop in investor participation.
In the broader market context, the pharmaceuticals and drugs sector has also faced challenges, with a decline of 2.35%. While Beryl Drugs has outperformed the benchmark over longer periods, such as a 3-year return of 121.68% compared to the Sensex's 40.74%, its recent performance has been starkly negative in the short term. The stock's current trading patterns show it is above its 50-day and 100-day moving averages but below its 5-day, 20-day, and 200-day moving averages, suggesting a bearish trend in the short term. Overall, the combination of falling investor participation, sector-wide declines, and significant recent losses has contributed to the stock's downward movement.